Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rawalpindi Institute Of Cardiology

Clinical trials sponsored by Rawalpindi Institute Of Cardiology, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a daily pill replace frequent blood tests for heart valve patients? Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet finished but already full! 1

Could a daily pill replace frequent blood tests for heart valve patients?

Disease control By invitation only

This study compares rivaroxaban, a newer blood thinner that doesn't need regular lab monitoring, to the standard drug warfarin in 60 adults with mechanical heart valves. The goal is to see if rivaroxaban can safely prevent blood clots and bleeding complications. Participants will…

Phase 3 • Sponsor: Rawalpindi Institute of Cardiology • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC